The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCGW.L Regulatory News (CGW)

  • There is currently no data for CGW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Belgravium Technologies plc

9 Jul 2014 09:54

RNS Number : 8461L
Chelverton Growth Trust PLC
09 July 2014
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Chelverton Growth Trust plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

n/a

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Belgravium Technologies plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

9 July 2014

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary 5p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,000,000

5.94

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

6,000,000

5.94

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

9 July 2014

Contact name:

Debbie Warburton

Telephone number:

01326 378 288

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUGUUAMUPCURB
Date   Source Headline
27th Nov 20233:42 pmRNSResult of Meeting
27th Nov 202310:30 amRNSSuspension - Chelverton Growth Trust plc
14th Nov 202312:36 pmRNSNet Asset Value(s)
1st Nov 20237:00 amRNSPublication of Circular and Notice of GM
9th Oct 20232:27 pmRNSNet Asset Value(s)
11th Sep 20234:41 pmRNSNet Asset Value(s)
25th Aug 20237:00 amRNSNet Asset Value(s)
4th Aug 202311:25 amRNSHolding(s) in Company
31st Jul 20239:59 amRNSHolding(s) in Company
31st Jul 20239:55 amRNSHolding(s) in Company
17th Jul 202311:02 amRNSNet Asset Value(s)
13th Jun 202310:28 amRNSNet Asset Value(s)
10th May 202311:09 amRNSNet Asset Value(s)
24th Apr 20237:00 amRNSHalf-year Report
6th Apr 20237:00 amRNSNet Asset Value(s)
20th Mar 20235:46 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:03 pmRNSNet Asset Value(s)
6th Feb 20237:00 amRNSNet Asset Value(s)
16th Jan 20232:56 pmRNSHolding(s) in Company
16th Jan 202310:58 amRNSNet Asset Value(s)
15th Dec 20222:06 pmRNSResult of AGM
7th Dec 20221:11 pmRNSNet Asset Value(s)
10th Nov 20227:00 amRNSNet Asset Value(s)
9th Nov 20227:00 amRNSFinal Results
11th Oct 202210:55 amRNSNet Asset Value(s)
23rd Sep 20227:00 amRNSNet Asset Value(s)
5th Aug 202211:56 amRNSNet Asset Value(s)
6th Jul 202212:53 pmRNSNet Asset Value(s)
13th Jun 202212:40 pmRNSNet Asset Value(s)
16th May 20223:52 pmRNSNet Asset Value(s)
14th Apr 20223:12 pmRNSHalf-year Report
6th Apr 20227:00 amRNSNet Asset Value(s)
21st Mar 20227:00 amRNSNet Asset Value(s)
10th Feb 202211:43 amRNSNet Asset Value(s)
12th Jan 20225:52 pmRNSNet Asset Value(s)
11th Jan 20221:03 pmRNSResult of AGM
20th Dec 20213:11 pmRNSNet Asset Value(s)
16th Nov 20211:51 pmRNSFinal Results
9th Nov 20212:48 pmRNSNet Asset Value(s)
6th Oct 202110:03 amRNSNet Asset Value(s)
30th Sep 20215:32 pmRNSHolding(s) in Company
27th Sep 20212:38 pmRNSNet Asset Value(s)
12th Aug 202112:27 pmRNSNet Asset Value(s)
11th Aug 20212:52 pmRNSHolding(s) in Company
11th Aug 20212:48 pmRNSHolding(s) in Company
6th Jul 20214:42 pmRNSNet Asset Value(s)
5th Jul 20211:56 pmRNSHolding(s) in Company
10th Jun 20213:28 pmRNSHolding(s) in Company
9th Jun 202112:01 pmRNSDirector/PDMR Shareholding
9th Jun 202111:59 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.